@misc{indiciaec0647c1f658c,
  title = {Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.},
  author = {Sherif S Farag and Stephen L George and Edward J Lee and Maria Baer and Richard K Dodge and Brian Becknell and Todd A Fehniger and Lewis R Silverman and Jeffrey Crawford and Clara D Bloomfield and Richard A Larson and Charles A Schiffer and Michael A Caligiuri},
  year = {2002},
  url = {https://pubmed.ncbi.nlm.nih.gov/12231521/},
  note = {Source identifier: 12231521}
}